White Paper Is Actually Branded Promotion, FDA Tells Ipsen
This article was originally published in The Pink Sheet Daily
Executive Summary
Warning letter states that when only one drug (Increlex in this case) provides a therapy discussed in promotional materials, they "effectively promote" the drug even if they do not mention it by name.